Finance2 years ago
Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought
[ad_1] Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products ByMICHELLE CHAPMAN...
